Ascendis Pharma A/S Ordinary Share share price logo

Ascendis Pharma A/S Ordinary Share

NASDAQ: ASND

Large Cap

$228.10

-2.73

(-1.18%)

as on

Ascendis Pharma A/S Ordinary Share Stock Performance

as on June 23, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $227.29
    $236.90
    downward going graph

    0.36%

    Downside

    3.86%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $160.86
    $250.74
    downward going graph

    29.48%

    Downside

    9.93%

    Upside

    downward going graph

Ascendis Pharma A/S Ordinary Share share price movements today

Previous Close
$230.83
Open
$233.00
Volume
629.9K
Day's Low - High
$227.29 - $236.90
52 Week Low - High
$160.86 - $250.74

Ascendis Pharma A/S Ordinary Share Historical Returns

1 Month Return
-6.57 %
3 Month Return
+ 4.03 %
1 Year Return
+ 30.49 %
3 Year Return
+ 159.74 %
5 Year Return
+ 64.89 %

Ascendis Pharma A/S Ordinary Share Stock Fundamentals & Key Indicators

Check Ascendis Pharma A/S Ordinary Share market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$15.1B

EPS (TTM)

11.447

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

26.26

Industry PE ratio

-4.0832

PEG Ratio

0

EBITDA

-10.2M

Revenue (TTM)

865.8M

Profit Margin

57.28%

Return On Equity TTM

33.27%

Ascendis Pharma A/S Ordinary Share Stock Valuation

Track how Ascendis Pharma A/S Ordinary Share P/E has moved over time to understand its valuation trends.

Ascendis Pharma A/S Ordinary Share in the last 5 years

  • Overview

  • Trends

Lowest (-101.44x)

March 31, 2026

Industry (-4.08x)

June 22, 2026

Today (26.26x)

June 22, 2026

Highest (-8.01x)

June 30, 2023

LowHigh

Today’s Price to Earnings Ratio: 26.26x

Ascendis Pharma A/S Ordinary Share vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ascendis Pharma A/S Ordinary Share with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Ascendis Pharma A/S Ordinary Share image
Ascendis Pharma A/S Ordinary Share
BUY$15.1B64.89%26.2657.28%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$37.1B60.79%69.8712.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$114.6B139.12%26.835.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$63.9B14.22%14.8829.65%0.59%

Stock Returns calculator for Ascendis Pharma A/S Ordinary Share Stock including INR - Dollar returns

The Ascendis Pharma A/S Ordinary Share stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Ascendis Pharma A/S Ordinary Share investment value today

Current value as on today

₹1,41,006

Returns

₹41,006

(+41.01%)

Returns from Ascendis Pharma A/S Ordinary Share Stock

₹28,943 (+28.94%)

Dollar Impact

₹12,063 (+12.06%)

Analyst Recommendation on Ascendis Pharma A/S Ordinary Share Stock

Based on 20 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 20 analysts, 80% of analysts recommend a 'BUY' rating for Ascendis Pharma A/S Ordinary Share. Average target price of $293.18

Ascendis Pharma A/S Ordinary Share Share Price Target

Get share price movements and forecasts by analysts on Ascendis Pharma A/S Ordinary Share.

What analysts predicted

22.2%UPSIDE

Target Price

$293.18

Current Price

$228.1

Analyzed by

20 Analysts

Target

$293.18

Ascendis Pharma A/S Ordinary Share target price $293.18, a slight upside of 22.2% compared to current price of $228.1. According to 20 analysts rating.

Indian Investors' Interest in Ascendis Pharma A/S Ordinary Share Stock

Search interest for Ascendis Pharma A/S Ordinary Share Stock has increased by 54% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:54% versus previous 30 day period

Ascendis Pharma A/S Ordinary Share Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
150
104
35
57
181
100
158
213
245
250
Gross Profit
128
96
24
46
167
83
126
191
217
229
Operating Income
-36
-49
-133
-96
0
-104
-52
10
9
25
EBITDA
-67
-46
-87
-71
-37
-44
2
-53
39
23
Interest Expense
68
77
19
25
56
44
33
19
61
68
Depreciation
4
4
4
1
4
4
4
4
4
4
Income Before Tax
-81
-128
-109
-98
-37
-93
-35
-57
-26
-48
Income Tax Expense
5
2
0
1
1
1
3
3
6
-688
Net Income
-94
-142
-109
-99
-40
-94
-38
-60
-33
639
Net Profit Margin
-63.09%
-136.65%
-303.85%
-171.52%
-22.12%
-93.73%
-24.58%
-28.55%
-13.56%
255.21%

Ascendis Pharma A/S Ordinary Share Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
4
1
12
14
8
8
54
290
380
691
Gross Profit
4
1
12
14
8
4
41
242
334
588
Operating Income
-72
-111
-154
-226
-330
-451
-561
-455
-278
-130
EBITDA
-72
-109
-150
-210
-407
-364
-529
-411
-290
-109
Interest Expense
0
0
0
1
1
3
30
44
65
77
Depreciation
-
0
0
6
9
15
17
18
17
17
Income Before Tax
-68
-124
-130
-218
-419
-383
-577
-474
-373
-204
Income Tax Expense
0
0
0
0
0
0
5
7
4
14
Net Income
-72
-146
-147
-242
-509
-433
-617
-525
-395
-219
Net Profit Margin
-1487.30%
-8097.84%
-1229.53%
-1630.03%
-6025.53%
-4931.56%
-1139.63%
-180.51%
-103.97%
-31.67%

Ascendis Pharma A/S Ordinary Share Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-131
-109
-99
-38
-94
-38
-60
-33
639
Operating Cash Flow
-101
-61
-56
-87
-14
-7
2
70
-7
Investing Cash Flow
7
0
0
0
0
-4
0
-3
-6
Financing Cash Flow
18
-2
427
0
-18
6
38
8
-37
Change in Cash
-71
-61
366
-65
-41
-23
45
76
-55

Ascendis Pharma A/S Ordinary Share Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-123
-130
-218
-418
-383
-583
-481
-378
-219
Operating Cash Flow
-95
-138
-175
-271
-417
-495
-467
-306
51
Investing Cash Flow
0
-2
-5
-291
-110
61
286
6
-8
Financing Cash Flow
124
203
493
602
351
396
134
443
34
Change in Cash
15
82
320
-13
-138
-1
-52
167
122

Global Institutional Holdings in Ascendis Pharma A/S Ordinary Share

Funds
Holdings
T. Rowe Price Associates, Inc.
2.54%
Capital World Investors
1.47%
The Goldman Sachs Group Inc
0.92%
JPMorgan Chase & Co
0.88%
venBio Select Advisor LLC
8.25%
See all

Insights on Ascendis Pharma A/S Ordinary Share

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, ASND stock has moved up by 3.4%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ASND has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 5 quarters, 100.95M → 250.65M (in $), with an average increase of 19.3% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -60.98M → 639.68M (in $), with an average increase of 94.3% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ASND has outperformed top 5 stocks with highest market-cap in its industry

About Ascendis Pharma A/S Ordinary Share

Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.
OrganisationAscendis Pharma A/S Ordinary Share
HeadquartersTuborg Boulevard 12, Hellerup, Denmark, 2900
IndustryBiotechnology
CEOMr. Jan Moller Mikkelsen
E-voting on sharesClick here to vote

Key Management of Ascendis Pharma A/S Ordinary Share

Name

Title

Dr. Stina Singel M.D., Ph.D.

Executive VP & Head of Clinical Development for Oncology

Mr. Jan Moller Mikkelsen

President, CEO, Member of Executive Board & Executive Director

Mr. Scott T. Smith

CFO, Executive VP & Member of Executive Board

Mr. Chad Fugure

Vice President of Investor Relations

Dr. Kennett Sprogoe Ph.D.

Executive VP and Head of Research & Product Development

Mr. Joseph Kelly

Head of U.S. Commercial of Endocrinology

Ms. Pedersen Anni Lotte Kirstine Sonderbjerg

Executive VP, Chief Administrative Officer & Member of the Executive Board

Mr. Michael Wolff Jensen L.L.M.

Executive VP, Chief Legal Officer & Member of the Executive Board

Mr. Mads Bodenhoff

Senior VP, Head of Finance & Principal Accounting Officer

Mr. Flemming Steen Jensen

Executive Vice President of Product Supply & Quality

FAQs

What is Ascendis Pharma A/S Ordinary Share share price today?

Ascendis Pharma A/S Ordinary Share share price today is $228.1 as on at the close of the market. Ascendis Pharma A/S Ordinary Share share today touched a day high of $236.9 and a low of $227.29.

What is the 52 week high and 52 week low for Ascendis Pharma A/S Ordinary Share share?

Ascendis Pharma A/S Ordinary Share share touched a 52 week high of $250.74 on and a 52 week low of $160.86 on . Ascendis Pharma A/S Ordinary Share stock price today i.e. is closed at $228.1,which is 9.03% down from its 52 week high and 41.80% up from its 52 week low.

What is Ascendis Pharma A/S Ordinary Share's market capitalisation today?

Ascendis Pharma A/S Ordinary Share market capitalisation is $0.02T as on .

How to invest in Ascendis Pharma A/S Ordinary Share Stock (ASND) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Ascendis Pharma A/S Ordinary Share on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ascendis Pharma A/S Ordinary Share Shares that will get you 0.0066 shares as per Ascendis Pharma A/S Ordinary Share share price of $228.1 per share as on June 23, 2026 at 1:29 am IST.

What is the minimum amount required to buy Ascendis Pharma A/S Ordinary Share Stock (ASND) from India?

Indian investors can start investing in Ascendis Pharma A/S Ordinary Share (ASND) shares with as little as ₹94.68 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.80 in Ascendis Pharma A/S Ordinary Share stock (as per the Rupee-Dollar exchange rate as on ). Based on Ascendis Pharma A/S Ordinary Share share’s latest price of $228.1 as on June 23, 2026 at 1:29 am IST, you will get 0.0438 shares of Ascendis Pharma A/S Ordinary Share. Learn more about fractional shares .

What are the returns that Ascendis Pharma A/S Ordinary Share has given to Indian investors in the last 5 years?

Ascendis Pharma A/S Ordinary Share stock has given 64.89% share price returns and 26.88% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?